SLC16A1 and cancer: Interestingly, the correlation between PKM and SLC16A1 in cancers is considerably weaker than it in NPCs as shown in Figure 3A and Figure S3, hence suggesting that the role of SLC16A1 might be different from the other pH-related transporters.